Authors
Shahin Akhondzadeh, M Shafiee Sabet, MH Harirchian, M Togha, H Cheraghmakani, S Razeghi, S Sh Hejazi, MH Yousefi, R Alimardani, A Jamshidi, F Zare, A Moradi
Publication date
2010/10
Journal
Journal of clinical pharmacy and therapeutics
Volume
35
Issue
5
Pages
581-588
Publisher
Blackwell Publishing Ltd
Description
What is known:  Herbal medicines have been used in the treatment of behavioural and psychological symptoms of dementia but with variable response. Crocus sativus (saffron) may inhibit the aggregation and deposition of amyloid β in the human brain and may therefore be useful in Alzheimer’s disease (AD).
Objective:  The goal of this study was to assess the efficacy of saffron in the treatment of mild to moderate AD.
Methods:  Forty‐six patients with probable AD were screened for a 16‐week, double‐blind study of parallel groups of patients with mild to moderate AD. The psychometric measures, which included AD assessment scale‐cognitive subscale (ADAS‐cog), and clinical dementia rating scale‐sums of boxes, were performed to monitor the global cognitive and clinical profiles of the patients. Patients were randomly assigned to receive capsule saffron 30 mg/day (15 mg twice per day) (Group A) or …
Total citations
2010201120122013201420152016201720182019202020212022202320242714172322212722263435342118
Scholar articles